S152: COMBINATORY THERAPY OF ASCIMINIB AND PONATINIB WAS EFFECTIVE IN THE TREATMENT OF BLAST PHASE CML CDX MODEL

Bibliographic Details
Main Authors: Nikola Čuřík, Adam Laznicka, Vaclava Polivkova, Jitka Křížková, Pavel Semerak, Eva Pokorna, Pavla Suchankova, Pavel Burda, Andreas Hochhaus, Kateřina Machová Poláková
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000967520.71557.f0
_version_ 1797280139097145344
author Nikola Čuřík
Adam Laznicka
Vaclava Polivkova
Jitka Křížková
Pavel Semerak
Eva Pokorna
Pavla Suchankova
Pavel Burda
Andreas Hochhaus
Kateřina Machová Poláková
author_facet Nikola Čuřík
Adam Laznicka
Vaclava Polivkova
Jitka Křížková
Pavel Semerak
Eva Pokorna
Pavla Suchankova
Pavel Burda
Andreas Hochhaus
Kateřina Machová Poláková
author_sort Nikola Čuřík
collection DOAJ
first_indexed 2024-03-07T16:36:54Z
format Article
id doaj.art-f028e86716ee4bd0bfe0dfd27a8cb9cf
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T16:36:54Z
publishDate 2023-08-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-f028e86716ee4bd0bfe0dfd27a8cb9cf2024-03-03T09:43:30ZengWileyHemaSphere2572-92412023-08-017e71557f010.1097/01.HS9.0000967520.71557.f0202308003-00054S152: COMBINATORY THERAPY OF ASCIMINIB AND PONATINIB WAS EFFECTIVE IN THE TREATMENT OF BLAST PHASE CML CDX MODELNikola Čuřík0Adam Laznicka1Vaclava Polivkova2Jitka Křížková3Pavel Semerak4Eva Pokorna5Pavla Suchankova6Pavel Burda7Andreas Hochhaus8Kateřina Machová Poláková91 Institute of Hematology and Blood Transfusion (ÚHKT), Czech Republic1 Institute of Hematology and Blood Transfusion (ÚHKT), Czech Republic1 Institute of Hematology and Blood Transfusion (ÚHKT), Czech Republic1 Institute of Hematology and Blood Transfusion (ÚHKT), Czech Republic2 2nd Medical School, Charles University, Czech Republic3 First Faculty of Medicine Charles University, Institute of Pathological Physiology, Czech Republic3 First Faculty of Medicine Charles University, Institute of Pathological Physiology, Czech Republic3 First Faculty of Medicine Charles University, Institute of Pathological Physiology, Czech Republic4 Klinik für Innere Medizin II - Hämatologie und Internistische Onkologie, Jena, Germany1 Institute of Hematology and Blood Transfusion (ÚHKT), Czech Republichttp://journals.lww.com/10.1097/01.HS9.0000967520.71557.f0
spellingShingle Nikola Čuřík
Adam Laznicka
Vaclava Polivkova
Jitka Křížková
Pavel Semerak
Eva Pokorna
Pavla Suchankova
Pavel Burda
Andreas Hochhaus
Kateřina Machová Poláková
S152: COMBINATORY THERAPY OF ASCIMINIB AND PONATINIB WAS EFFECTIVE IN THE TREATMENT OF BLAST PHASE CML CDX MODEL
HemaSphere
title S152: COMBINATORY THERAPY OF ASCIMINIB AND PONATINIB WAS EFFECTIVE IN THE TREATMENT OF BLAST PHASE CML CDX MODEL
title_full S152: COMBINATORY THERAPY OF ASCIMINIB AND PONATINIB WAS EFFECTIVE IN THE TREATMENT OF BLAST PHASE CML CDX MODEL
title_fullStr S152: COMBINATORY THERAPY OF ASCIMINIB AND PONATINIB WAS EFFECTIVE IN THE TREATMENT OF BLAST PHASE CML CDX MODEL
title_full_unstemmed S152: COMBINATORY THERAPY OF ASCIMINIB AND PONATINIB WAS EFFECTIVE IN THE TREATMENT OF BLAST PHASE CML CDX MODEL
title_short S152: COMBINATORY THERAPY OF ASCIMINIB AND PONATINIB WAS EFFECTIVE IN THE TREATMENT OF BLAST PHASE CML CDX MODEL
title_sort s152 combinatory therapy of asciminib and ponatinib was effective in the treatment of blast phase cml cdx model
url http://journals.lww.com/10.1097/01.HS9.0000967520.71557.f0
work_keys_str_mv AT nikolacurik s152combinatorytherapyofasciminibandponatinibwaseffectiveinthetreatmentofblastphasecmlcdxmodel
AT adamlaznicka s152combinatorytherapyofasciminibandponatinibwaseffectiveinthetreatmentofblastphasecmlcdxmodel
AT vaclavapolivkova s152combinatorytherapyofasciminibandponatinibwaseffectiveinthetreatmentofblastphasecmlcdxmodel
AT jitkakrizkova s152combinatorytherapyofasciminibandponatinibwaseffectiveinthetreatmentofblastphasecmlcdxmodel
AT pavelsemerak s152combinatorytherapyofasciminibandponatinibwaseffectiveinthetreatmentofblastphasecmlcdxmodel
AT evapokorna s152combinatorytherapyofasciminibandponatinibwaseffectiveinthetreatmentofblastphasecmlcdxmodel
AT pavlasuchankova s152combinatorytherapyofasciminibandponatinibwaseffectiveinthetreatmentofblastphasecmlcdxmodel
AT pavelburda s152combinatorytherapyofasciminibandponatinibwaseffectiveinthetreatmentofblastphasecmlcdxmodel
AT andreashochhaus s152combinatorytherapyofasciminibandponatinibwaseffectiveinthetreatmentofblastphasecmlcdxmodel
AT katerinamachovapolakova s152combinatorytherapyofasciminibandponatinibwaseffectiveinthetreatmentofblastphasecmlcdxmodel